• Compatibility
  • Incompatibility
  • Neonatal Intensive Care Drug Manual




    Download 1,5 Mb.
    bet283/654
    Sana03.01.2022
    Hajmi1,5 Mb.
    #14803
    1   ...   279   280   281   282   283   284   285   286   ...   654
    Adverse reactions

    Prophylactic use of ibuprofen is associated increased risks for oliguria, increase in serum creatinine levels, and increased risk of gastrointestinal haemorrhage.[5]. [LOE I]

    Ibuprofen for treatment of a PDA was associated with increased oliguria and increased creatinine. [LOE I]

    Compared to treatment of a PDA with indomethacin, ibuprofen was associated with reduced NEC, reduced oliguria and was associated with lower creatinine levels 72 hours after initiation of treatment.[6].[LOE I]

    Compared to paracetamol (acetaminophen), ibuprofen was associated with a high rate of gastrointestinal bleeding, higher creatinine and bilirubin levels, and lower platelet counts and daily urine output. [7].

    There have been reports of pulmonary hypertension with use of ibuprofen, [5, 6] although the rate may be similar to that reported for indomethacin.[8].

    Ibuprofen may displace bilirubin from albumin at high concentrations in vitro (200 micromol/L), [9] although this does not appear to occur in vivo at the concentrations associated with recommended doses (up to 100 micromol/L). [10].



    Compatibility

    Fluids: Pedea, neoprofen, caldolor - Sodium chloride 0.9%, glucose 5%. NeoProfen only- sterile water for injection.36

    Y site: Pedea : Not tested.

    Y site: Neoprofen: Ceftazidime, epinephrine hydrochloride, furosemide, heparin sodium, insulin, phenobarbital sodium, potassium chloride, sodium bicarbonate

    Y site: Caldolor: Metoprolol tartrate




    Incompatibility

    Caldolor (ibuprofen arginine), Neoprofen (ibuprofen lysine) and Pedea (ibuprofen sodium) - regard all other IV solutions and drugs as incompatible.

    Stability

    Caldolor: Diluted solutions are stable for up to 24 hours at room temperature (20−25° C) and room lighting.

    Neoprofen and Pedea: Discard unused portion once opened.



    Storage

    IV − store unopened vials at room temperature (20−25°C).

    Oral liquid − store below 25°C.



    Excipients

    PEDEA - Each 1 ml of PEDEA contains the following inactive ingredients: trometamol (3.78 mg), sodium hydroxide (0.14 mg), sodium chloride (7.3 mg), hydrochloric acid and water for injections. The headspace within the ampoules is filled with nitrogen.
    Caldolor – Each 1 mL of Caldolor also contains 78 mg of arginine at a molar ratio of 0.92:1 arginine: ibuprofen. Hydrochloric acid is added for pH adjustment.
    Neoprofen - Each mL of NeoProfen contains 17.1 mg of ibuprofen lysine (equivalent to 10 mg of (±)-ibuprofen) in Water for Injection. The pH is adjusted to 7.0 with sodium hydroxide or hydrochloric acid.
    Fenpaed - contains glycerol, xanthan gum, maltitol, polysorbate 80, saccharin sodium, citric acid monohydrate, sodium methyl hydroxybenzoate, sodium propyl hydroxybenzoate, purified water and strawberry flavour.


    Download 1,5 Mb.
    1   ...   279   280   281   282   283   284   285   286   ...   654




    Download 1,5 Mb.

    Bosh sahifa
    Aloqalar

        Bosh sahifa



    Neonatal Intensive Care Drug Manual

    Download 1,5 Mb.